Selective Inhibition of Anthrax Edema Factor by Adefovir, a Drug for Chronic Hepatitis B Virus Infection

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0306552101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Selective Inhibition of Hepatitis C Virus Infection by Hydroxyzine and Benztropine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Treatment of Chronic Hepatitis B Virus Infection With Rebavrin.

BMJ
1977English

Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil

Gut
Gastroenterology
2006English

Serum HBV RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection

Hepatology
MedicineHepatology
2019English

Novel Inhibitors of Anthrax Edema Factor

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2008English

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Structural Basis of Anthrax Edema Factor Neutralization by a Neutralizing Antibody

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2012English

Comparison of Three Luminescent Immunoassays for Hepatitis B Virus Surface Antigen Quantification During the Natural History of Chronic Hepatitis B Virus Infection

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2014English

Chronic Hepatitis C Virus Infection: A New Modifiable Cardio-Metabolic Risk Factor ?

Medicine and Pharmacy Reports
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy